Schedule 13G ownership disclosure

Protagonist Therapeutics Inc

Security class unavailable · CUSIP: 74366E102

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,449,183
Percent of class
4.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000904454-23-000019
Form type
SC 13G/A
Filer
JOHNSON & JOHNSON
CIK
CIK 200406
Filed
Jan 11, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub